National Institute of Neurological Disorders and Stroke; Notice of Meeting, 77596 [2023-24963]
Download as PDF
<![CDATA[
77596
Federal Register / Vol. 88, No. 217 / Monday, November 13, 2023 / Notices
Date: December 15, 2023.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G42B,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Louis A. Rosenthal, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G42B, Rockville, MD
20852, (240) 669–5070, rosenthalla@
niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: November 7, 2023.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2023–24965 Filed 11–9–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS.)
National Institutes of Health
khammond on DSKJM1Z7X2PROD with NOTICES
National Institute of Neurological
Disorders and Stroke; Notice of
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
Neurological Disorders and Stroke
Council.
The meeting will be partially open to
the public as indicated below.
Individuals who plan to participate and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be partially closed
to the public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5, U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council.
Date: February 14–15, 2024.
Open: February 14, 2024, 10:00 a.m. to 4:00
p.m.
VerDate Sep<11>2014
17:12 Nov 09, 2023
Jkt 262001
Agenda: Report by the Director, NINDS;
Report by the Director, Division of
Extramural Activities; and Administrative
and Program Developments
Open session will be videocast from this
link: https://videocast.nih.gov/watch=52772.
Closed: February 14, 2024, 4:00 p.m. to
5:30 p.m.
February 15, 2024, 9:30 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6001
Executive Boulevard, Room 1131, Rockville,
Maryland 20852 (Virtual Meeting).
Contact Person: David Owens, Ph.D.,
Director of Extramural Activities (Acting),
National Institute of Neurological Disorders
and Stroke, NIH, 6001 Executive Blvd., 5th
Floor, MSC 9531, Bethesda, MD 20892, (301)
496–9248, owensd@ninds.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice at least 10 days in advance of the
meeting. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page:
www.ninds.nih.gov, where an agenda and
any additional information for the meeting
will be posted when available.
Dated: November 7, 2023.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2023–24963 Filed 11–9–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Amended Notice of Meeting
Notice is hereby given of a change in
the meeting of the Sickle Cell Disease
Advisory Committee, January 29, 2024,
10:00 a.m. to January 29, 2024, 3:00
p.m., National Institutes of Health,
Rockledge I, 6705 Rockledge Drive,
Bethesda, MD 20892 which was
published in the Federal Register on
September 28, 2023, FR Doc 2023–
21315, 88 FR 67324.
This Notice is being amended to
update the Registration Link. The event
is free and open to the public; however,
registration is required. Please use this
included link to register: https://
nih.zoomgov.com/webinar/register/WN_
X-5kA5CJQG6Qmk_ujQsqAw.
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
Dated: November 7, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–24962 Filed 11–9–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Mentored Patient Oriented Review.
Date: November 17, 2023.
Time: 1:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Fungai Chanetsa, Ph.D.,
MPH, Scientific Review Officer, Office of
Scientific Review/DERA, National Heart,
Lung, and Blood Institute National Institutes
of Health, 6705 Rockledge Drive, Room 206–
B, Bethesda, MD 20817, (301) 402–9394,
fungai.chanetsa@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: November 7, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–24926 Filed 11–9–23; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\13NON1.SGM
13NON1
]]>Agencies
[Federal Register Volume 88, Number 217 (Monday, November 13, 2023)]
[Notices]
[Page 77596]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-24963]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Advisory
Neurological Disorders and Stroke Council.
The meeting will be partially open to the public as indicated
below. Individuals who plan to participate and need special assistance,
such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
The meeting will be partially closed to the public in accordance
with the provisions set forth in sections 552b(c)(4) and 552b(c)(6),
title 5, U.S.C., as amended. The grant applications and the discussions
could disclose confidential trade secrets or commercial property such
as patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Neurological Disorders and
Stroke Council.
Date: February 14-15, 2024.
Open: February 14, 2024, 10:00 a.m. to 4:00 p.m.
Agenda: Report by the Director, NINDS; Report by the Director,
Division of Extramural Activities; and Administrative and Program
Developments
Open session will be videocast from this link: https://videocast.nih.gov/watch=52772.
Closed: February 14, 2024, 4:00 p.m. to 5:30 p.m.
February 15, 2024, 9:30 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6001 Executive Boulevard,
Room 1131, Rockville, Maryland 20852 (Virtual Meeting).
Contact Person: David Owens, Ph.D., Director of Extramural
Activities (Acting), National Institute of Neurological Disorders
and Stroke, NIH, 6001 Executive Blvd., 5th Floor, MSC 9531,
Bethesda, MD 20892, (301) 496-9248, [email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice at least 10 days in advance of the meeting. The
statement should include the name, address, telephone number and
when applicable, the business or professional affiliation of the
interested person.
Information is also available on the Institute's/Center's home
page: www.ninds.nih.gov, where an agenda and any additional
information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS.)
Dated: November 7, 2023.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2023-24963 Filed 11-9-23; 8:45 am]
BILLING CODE 4140-01-P
